Chemours Historical Balance Sheet
CC Stock | USD 26.84 0.31 1.14% |
Trend analysis of Chemours Co balance sheet accounts such as Total Assets of 7.5 B or Other Current Liabilities of 1.3 B provides information on Chemours' total assets, liabilities, and equity, which is the actual value of Chemours to its prevalent stockholders. By breaking down trends over time using Chemours balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Chemours latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Chemours is a good buy for the upcoming year.
Chemours Inventory |
|
Chemours |
About Chemours Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Chemours at a specified time, usually calculated after every quarter, six months, or one year. Chemours Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Chemours and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Chemours currently owns. An asset can also be divided into two categories, current and non-current.
Chemours Balance Sheet Chart
Chemours Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Chemours uses and utilizes its capital. It also shows what exactly a company owns and owes.
At present, Chemours' Total Stockholder Equity is projected to decrease significantly based on the last few years of reporting. The current year's Property Plant And Equipment Net is expected to grow to about 3.6 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 140.1 M. Add Fundamental
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Total Assets
Total assets refers to the total amount of Chemours assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Chemours books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Chemours balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Chemours Co are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Most accounts from Chemours' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Chemours current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. At present, Chemours' Total Stockholder Equity is projected to decrease significantly based on the last few years of reporting. The current year's Property Plant And Equipment Net is expected to grow to about 3.6 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 140.1 M.
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 668M | 554M | 1.2B | 1.3B | Total Assets | 7.6B | 7.6B | 8.3B | 7.5B |
Chemours balance sheet Correlations
Click cells to compare fundamentals
Chemours Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Chemours balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 164.8M | 166.3M | 168.7M | 158.3M | 148.9M | 140.1M | |
Total Assets | 7.3B | 7.1B | 7.6B | 7.6B | 8.3B | 7.5B | |
Other Current Liab | 477M | 537M | 668M | 554M | 1.2B | 1.3B | |
Total Current Liabilities | 1.5B | 1.4B | 1.9B | 1.9B | 2.5B | 1.8B | |
Total Stockholder Equity | 689M | 813M | 1.1B | 1.1B | 737M | 1.1B | |
Other Liab | 751M | 626M | 707M | 854M | 982.1M | 711.9M | |
Property Plant And Equipment Net | 3.9B | 3.7B | 3.4B | 3.4B | 3.5B | 3.6B | |
Accounts Payable | 923M | 820M | 1.2B | 1.3B | 1.1B | 1.1B | |
Non Current Assets Total | 4.5B | 4.4B | 4.2B | 4.4B | 4.4B | 4.4B | |
Non Currrent Assets Other | 391M | 252M | 310M | 573M | 374M | 416.1M | |
Other Assets | 292M | 405M | 547M | 725M | 833.8M | 424.1M | |
Long Term Debt | 4.0B | 4.0B | 3.7B | 3.6B | 4.0B | 3.2B | |
Net Receivables | 674M | 511M | 720M | 626M | 610M | 602.4M | |
Liabilities And Stockholders Equity | 7.3B | 7.1B | 7.6B | 7.6B | 8.3B | 7.5B | |
Non Current Liabilities Total | 5.0B | 4.8B | 4.6B | 4.6B | 5.0B | 4.1B | |
Inventory | 1.1B | 939M | 1.1B | 1.4B | 1.4B | 1.2B | |
Other Current Assets | 81M | 78M | 75M | 82M | 66M | 64.8M | |
Other Stockholder Equity | (213M) | (182M) | (303M) | (722M) | (773M) | (734.4M) | |
Total Liab | 6.6B | 6.3B | 6.5B | 6.5B | 7.5B | 6.0B | |
Property Plant And Equipment Gross | 3.9B | 3.7B | 9.2B | 9.4B | 9.6B | 5.2B | |
Total Current Assets | 2.8B | 2.6B | 3.3B | 3.2B | 3.8B | 3.0B | |
Accumulated Other Comprehensive Income | (349M) | (310M) | (364M) | (343M) | (274M) | (287.7M) | |
Short Term Debt | 13M | 134M | 78M | 25M | 106M | 86.1M | |
Intangible Assets | 28M | 21M | 14M | 6M | 3M | 2.9M | |
Property Plant Equipment | 3.9B | 3.5B | 3.4B | 3.2B | 3.6B | 3.5B | |
Net Tangible Assets | 515M | 646M | 973M | 992M | 892.8M | 710.5M | |
Retained Earnings | 1.2B | 1.3B | 1.7B | 2.2B | 1.8B | 1.1B | |
Cash | 943M | 1.1B | 1.5B | 1.1B | 1.8B | 1.2B | |
Deferred Long Term Liab | 148M | 36M | 49M | 61M | 54.9M | 96.1M | |
Long Term Investments | 162M | 167M | 169M | 175M | 158M | 171.6M | |
Short Long Term Debt | 13M | 134M | 21M | 25M | 51M | 41.5M | |
Short Long Term Debt Total | 4.4B | 4.3B | 3.9B | 3.8B | 4.3B | 4.4B | |
Net Debt | 3.5B | 3.2B | 2.5B | 2.7B | 2.5B | 2.3B | |
Cash And Short Term Investments | 943M | 1.1B | 1.5B | 1.1B | 1.8B | 1.3B | |
Retained Earnings Total Equity | 1.2B | 1.3B | 1.7B | 2.2B | 2.5B | 2.6B | |
Long Term Debt Total | 4.0B | 4.0B | 3.7B | 3.6B | 3.2B | 3.1B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Chemours offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chemours' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chemours Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chemours Co Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Transaction History View history of all your transactions and understand their impact on performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.65) | Dividend Share 1 | Earnings Share (2.22) | Revenue Per Share 39.222 | Quarterly Revenue Growth (0.12) |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.